High Sensitivity C-Reactive Protein (hsCRP) Assay

Marking cardiac risk assessment while serving as a biomarker for systematic inflammation

High Sensitivity C-Reactive Protein (hsCRP) Assay
Contact Us

The AHA/CDC Scientific Statement Summary1,2

hsCRP is a global indicator of future vascular events in adults without any previous history of cardiovascular disease (CVD), with acceptable precision levels down to or below 0.3 mg/L

  • hsCRP enhances risk assessment and therapeutic outcomes in primary CVD prevention
  • hsCRP is particularly advantageous for assessing the risk in patients with
                o Framingham 10-year risk scores of 10%-20% and/or
                o LDL levels of <160 mg/dL
  • hsCRP acts as an independent marker for evaluating the possibility of recurrent cardiac events, such as myocardial infarction or restenosis, after percutaneous coronary intervention

Related Products, Services & Resources

1) Pearson TA, et al. Circulation. 2003;107:499-511. http://circ.ahajournals.org/cgi/content/full/107/3/499
2) Ridker PM. Circulation. 2003;107:363-369. http://circ.ahajournals.org/cgi/content/full/107/3/363